British Court Upholds Main Pfizer Patent on Lipitor

Drug Industry Daily
KEYWORDS courts / Patents
A A

The British High Court of Justice has upheld Pfizer’s main patent for blockbuster cholesterol drug Lipitor, but invalidated a second patent, in a case brought by Ranbaxy Laboratories and Arrow Generics.

To View This Article:

Login

Subscribe To Drug Industry Daily